GlassScriptPhysician profile
Michelle Ryder
NPI 1487812780
$2,186.01
in general payments reported to CMS, 2019-2025
20 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $395 · 2022: $657 · 2023: $689 · 2024: $309 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,039 · Education: $94.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,038.53 |
| Education | $94.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $646.82 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $515.81 | 2021-2024 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $178.52 | 2023-2024 | Sotyktu |
| Lilly USA, LLC | $122.33 | 2021-2022 | |
| Leo Pharma INC. | $113.66 | 2021-2024 | Adbry |
| Genzyme Corporation | $103.29 | 2021 | |
| Sun Pharmaceutical Industries INC. | $92.88 | 2021-2024 | |
| Incyte Corporation | $92.55 | 2022 | |
| Janssen Biotech, INC. | $54.82 | 2022 | |
| Pfizer INC. | $45.36 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $39.58 | 2022-2025 | |
| Lnhc, INC | $31.23 | 2025 | Zelsuvmi |
| Ucb, INC. | $29.14 | 2022 | |
| Verrica Pharmaceuticals INC. | $21.23 | 2025 | Ycanth |
| Organon LLC | $19.85 | 2025 | Vtama |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $18.00 | 2025 | Zoryve |
| Celgene Corporation | $16.26 | 2024 | Sotyktu |
| Amgen INC. | $15.67 | 2025 | Otezla |
| Strata Skin Sciences, INC. | $15.55 | 2022 | |
| Galderma Laboratories, L.P. | $13.46 | 2025 | Aklief |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Ryder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.